Large-scale testing (Phase 3)Ended earlyNCT02208063What this trial is testingTelavancin Staphylococcus Aureus (S. Aureus) Bacteremia TrialWho this might be right forBacteremia Cumberland Pharmaceuticals 121
Not applicableStudy completedNCT03029039What this trial is testingPlatelet-associated Inflammation in Severe SepsisWho this might be right forSevere Sepsis Centre Hospitalier Universitaire de Saint Etienne 127
Not applicableStudy completedNCT00548002What this trial is testingCombination Therapy With Fluoroquinolone in Staphylococcus Aureus BacteremiaWho this might be right forStaphylococcus AureusBacteremiaEndocarditis+1 more University of Helsinki 430
Testing effectiveness (Phase 2)Looking for participantsNCT04886284What this trial is testingCombination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus BacteremiaWho this might be right forStaphylococcus Aureus BacteremiaStaphylococcus Aureus SepticemiaStaphylococcal Sepsis+1 more Todd C. Lee MD MPH FIDSA 60
Not applicableStudy completedNCT03992703What this trial is testingClinical Impact of Rapid AST Directly From Blood CulturesWho this might be right forBacterial Infections Fondation Hôpital Saint-Joseph 160
Not applicableStudy completedNCT00175370What this trial is testingVancomycin Study: Treatment of Catheter Related Bloodstream Infection Caused by Coagulase Negative StaphylococcusWho this might be right forStaphylococcal Infections University of British Columbia 60
Not applicableStudy completedNCT03248063What this trial is testingNon-inferiority Trial Comparing Cloxacillin vs Cefazolin in Methicillin-susceptible Staphylococcus Aureus BacteremiaWho this might be right forBacteremia Due to Methicillin Susceptible Staphylococcus Aureus Assistance Publique - Hôpitaux de Paris 315
Testing effectiveness (Phase 2)Study completedNCT01321879What this trial is testingStudy to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer PatientsWho this might be right forInfectionBacteremia M.D. Anderson Cancer Center 40
Not applicableUnknownNCT01352936What this trial is testingComparison of Nephrotoxicity and Hospital Costs in Patients With Methicillin-Resistant Staphylococcus Aureus Bacteremia Who Received Vancomycin Versus Teicoplanin TherapyWho this might be right forStaphylococcus AureusBacteremia Taipei Medical University WanFang Hospital 190
Testing effectiveness (Phase 2)Looking for participantsNCT06749457What this trial is testingEvaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)Who this might be right forStaphylococcus Aureus AstraZeneca 231
Large-scale testing (Phase 3)Study completedNCT00093067What this trial is testingDaptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. AureusWho this might be right forBacterial EndocarditisBacteremia Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Testing effectiveness (Phase 2)Ended earlyNCT00695903What this trial is testingPhase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA BacteremiaWho this might be right forEndocarditis, BacterialInfective Endocarditis Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 38
Testing effectiveness (Phase 2)Study completedNCT04775953What this trial is testingDOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus BacteremiaWho this might be right forStaphylococcal Bacteraemia National Institute of Allergy and Infectious Diseases (NIAID) 200
Not applicableStudy completedNCT01255943What this trial is testingTesting Spread and Implementation of Novel Methicillin Resistant Staphylococcal Aureus (MRSA)-Reducing PracticesWho this might be right forBlood Stream InfectionsMRSA Infections MaineHealth 175
Large-scale testing (Phase 3)Study completedNCT00770341What this trial is testingMK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002)Who this might be right forStaphylococcal Infection Merck Sharp & Dohme LLC 122
Large-scale testing (Phase 3)Study completedNCT03138733What this trial is testingCeftobiprole in the Treatment of Patients With Staphylococcus Aureus BacteremiaWho this might be right forStaphylococcus Aureus Bacteremia Basilea Pharmaceutica 390
Not applicableLooking for participantsNCT06457386What this trial is testingEchocardiography Versus no Echocardiography in S. Aureus Bacteraemia and VIRSTA Score < 3Who this might be right forStaphylococcus AureusBacteremiaInfective Endocarditis Assistance Publique - Hôpitaux de Paris 700
Post-approval studies (Phase 4)Study completedNCT02972983What this trial is testingDaptomycin as Adjunctive Therapy for Staphylococcus Aureus BacteremiaWho this might be right forMethicillin Susceptible Staphylococcus Aureus SepticemiaBacteremia McGill University Health Centre/Research Institute of the McGill University Health Centre 102
Not applicableStudy completedNCT04503252What this trial is testingProbability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus AureusWho this might be right forStaphylococcus Aureus Infection University Hospital, Basel, Switzerland 50
Testing effectiveness (Phase 2)WithdrawnNCT00505258What this trial is testingCeftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus BacteremiaWho this might be right forBacteremia Basilea Pharmaceutica